Rancho BioSciences Launches OmicsHQ™: a Comprehensive, Curated, Multi-Omics Data Platform Built to Accelerate Drug Discovery

OmicsHQ brings together comprehensive, expertly curated, standardized multi-omics datasets from across the scientific ecosystem, complete with pre-processed datasets ready to accelerate research, drug-discovery, and AI-driven innovation. SAN DIEGO -- Today Rancho BioSciences, the premier tech-enabled data science partner for biopharma, announced the launch of OmicsHQTM, a unified catalog of expertly curated, standardized multi-omics datasets designed for immediate [...]

Blank Bio Announces Seed Financing and Strategic Collaboration with PacBio to Advance RNA Foundation Models for Precision Oncology

Collaboration with PacBio will generate long-read bulk RNA-seq data to advance patient-level prediction from tumor transcriptomes SAN FRANCISCO -- Blank Bio, an applied AI research lab training foundation models for RNA, today announced the closing of a $7.2 million seed financing and a strategic collaboration with Pacific Biosciences (Nasdaq: PACB), a leading developer of high-quality, [...]

Atrandi Biosciences Expands Leadership Team to Accelerate Global Adoption of Capsule-Based Single-Cell Technology

Company appoints Sam Ropp as Chief Commercial Officer and Susan Tousi to Board of Directors BOSTON -- Atrandi Biosciences, a life science tools company pioneering Semi-Permeable Capsule (SPC) technology for single-cell and multiomics research, today announced the appointment of Sam Ropp, PhD, as Chief Commercial Officer and Susan Tousi as Chairman of the Board of Directors. [...]

DNAnexus Scales AI-Driven Capabilities

17-Year Multiomics Pioneer Powers Next Era of Precision Health MOUNTAIN VIEW, Calif. -- Today, DNAnexus signals a bold new chapter in AI-powered precision health with several new product innovations and solution packages that extend its position as the purpose-built platform where the world's most scientifically complex data becomes the world's most powerful AI fuel. These [...]

Gustave Roussy and One Biosciences Partner to Bring Single Cell to Clinical Practice for Precision Oncology

PARIS -- #AI--Gustave Roussy partners with One Biosciences, a techbio company that harnesses single cell technology and AI to develop advanced precision diagnostics. The collaboration aims to further demonstrate the feasibility and impact of integrating single nuclei transcriptomic analysis into the patient care pathway. Gustave Roussy, Europe’s leading cancer center, is teaming up with One [...]

Industry Leader Francisco De La Vega Joins Ultima to Accelerate Advancements in Germline Genome Sequencing

FREMONT, Calif. -- Ultima Genomics today announced Francisco De La Vega, DSc, has joined the Company as Vice President, Germline Genomics & Distinguished Scientific Fellow. With over 25 years of leadership experience in human genetics, computational biology, and bioinformatics, Francisco will drive Ultima's inherited genome analysis applications to unlock insights into genetic diseases, population health, [...]

Quantori and Knowledge3 Announce Co-Marketing Partnership to Advance Knowledge-Driven AI in Life Sciences

CAMBRIDGE, Mass. -- Quantori, a leading provider of digital transformation services and technology for the life sciences and healthcare industries, today announced a co-marketing partnership with Knowledge3 (K3), a company focused on bridging the gap between business goals and IT delivery through Knowledge Graphs, FAIR data principles, and graph-grounded Generative AI. The partnership brings together Quantori’s [...]

Swiss Rockets Appoints Dana Novac, MD, MA, as Chief Medical Officer

Basel, Switzerland — Swiss Rockets today announced the appointment of Dana Novac, MD, MA, as Chief Medical Officer (CMO). Dr. Novac previously served as Senior Medical Director at Swiss Rockets AG, where she led oncology and dermatology clinical development programs and contributed to the broader clinical strategy across the company’s portfolio. Dr. Novac succeeds Bruno [...]

Sino Biological Launches XPressMAX™ Cell-Free Protein Synthesis Kit, Accelerating AI-Powered High-Throughput Antibody Drug Discovery

Ultra-Fast Protein/Antibody Synthesis in 3 Hours, Speed Up AI-Powered HTP Screening HOUSTON, TEXAS - Sino Biological, Inc. (Shenzhen Stock Exchange: 301047.SZ), a global leader in recombinant technology, is proud to announce the launch of its innovative XPressMAX™ Cell-Free Protein Synthesis Kit (Cat#: CFKIT02) , a cutting-edge solution designed to supercharge artificial intelligence (AI)-driven high-throughput screening pipelines for antibody drug discovery. XPressMAX™ [...]

Cerillo and Hamilton Company to Join Forces for Expanded Detection and Analysis Capabilities

Strategic combination brings together synergistic teams and technologies to deliver integrated, end-to-end solutions for life sciences. RENO, NV and CHARLOTTESVILLE, VA – Hamilton Company and Cerillo today announced that they will be joining forces in a strategic combination that unites Hamilton’s global leadership in liquid handling and automation with Cerillo’s innovative compact microplate reader technology. This [...]

Access IBO on Knowledge Center